<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03060954</url>
  </required_header>
  <id_info>
    <org_study_id>PSM29</org_study_id>
    <nct_id>NCT03060954</nct_id>
  </id_info>
  <brief_title>Non-Inferiority Study Comparing MINI WELL READY ® and FineVision ® in Patients With Cataract Surgery</brief_title>
  <official_title>Multicentre, Controled, Randomised, Singleblind, Two-armed, Non Inferiority Trial Evaluating the Visual Performance,Quality of Vision After Bilateral Implantation of MINI WELL READY®, or FINEVISION® in Patients With Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SIFI MedTech Srl</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Opera Contract Research Organization SRL</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>SIFI MedTech Srl</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional, Multicentre, controlled, randomized, single blind, twoarmed non-inferiority
      trial
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the non-inferiority of the progressive extended depth of focus Intraocular Lens
      MINI WELL READY® in terms of visual performance, quality of vision and subjective outcomes
      versus the trifocal Intraocular Lens FineVision® after a follow up period of 2-6 months.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 28, 2018</start_date>
  <completion_date type="Anticipated">April 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Defocus curve - binocular</measure>
    <time_frame>2- 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Refraction</measure>
    <time_frame>2- 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reading speed at 40cm</measure>
    <time_frame>2- 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast sensitivity - binocular distance</measure>
    <time_frame>2- 6 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Uncorrected Distance Visual Acuity</measure>
    <time_frame>2- 6 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Visual Disorder</condition>
  <arm_group>
    <arm_group_label>MINI WELL READY ®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BILATERAL IMPLANTATION OF MINI WELL READY®, A PROGRESSIVE EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS IN PATIENTS WITH CATARACT SURGERY</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FineVision ®</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>FINE VISION®, A TRIFOCAL INTRAOCULAR LENS IMPLANTATION IN PATIENTS WITH CATARACT SURGERY</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MINI WELL READY ®</intervention_name>
    <description>BILATERAL IMPLANTATION OF MINI WELL READY®, A PROGRESSIVE EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS IN PATIENTS WITH CATARACT SURGERY</description>
    <arm_group_label>MINI WELL READY ®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FINE VISION®</intervention_name>
    <description>FINE VISION®, A TRIFOCAL INTRAOCULAR LENS IMPLANTATION IN PATIENTS WITH CATARACT SURGERY</description>
    <arm_group_label>FineVision ®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bilateral cataract surgery required, no other ocular comorbidities

          -  Healthy corneas, not treated surgically

          -  Available for second-eye surgery within 1 week of the initial operation

          -  Spherical refraction between -8.00D and +6.00D

          -  Willing to adhere to the study visit schedule

          -  Normal anterior and posterior segments

          -  Clear intraocular media - other than cataract

          -  Written informed consent consistent with local regulation research in human subjects

        Exclusion Criteria:

          -  Any previous history of ocular trauma or prior ocular surgery (including previous
             cataract surgery and s)

          -  Ocular comorbidities determining potential postoperative Visual Acuity less than 0.50
             decimal (0.3 logMAR)

          -  Expected to require retinal laser treatment

          -  Psudoexfoliation

          -  Abnormal pupil size and position

          -  Pupil size &gt; 7 mm under mesopic condition

          -  Use of contact lenses 30 days before the preoperative visit

          -  Corneal warpage (e.g. Keratoconus, Pellucid Marginal Corneal Degeneration or
             Keratoglobus)

          -  Corneal astigmatism greater than 0.75D

          -  Active ocular disease in the operative eye, for example, chronic uveitis,
             proliferative diabetic retinopathy, chronic glaucoma unresponsive to medication,
             corneal decompensation and corneal endothelial cell insufficiency (such as Fuch's
             endothelial dystrophy)

          -  Subjects with any systemic disease that could increase operative risk or confound the
             outcome

          -  Pregnant or lactating or planning a pregnancy at the time of enrolment

          -  Subjects participating in a concurrent clinical trial or if they have participated in
             an ophthalmology clinical trial within the last 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Béatrice Cochener, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ophtalmologie Hôpital Morvan, Brest, FRANCE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gianluca Stivale, PharmD</last_name>
    <phone>+390957922335</phone>
    <email>gianluca.stivale@sifigroup.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dionisio Barattini, MD</last_name>
    <phone>+393355437574</phone>
    <email>barattini@operacro.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Opera Contract Research Organization Srl</name>
      <address>
        <city>Timisoara</city>
        <state>Timis</state>
        <zip>300209</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2017</study_first_submitted>
  <study_first_submitted_qc>February 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2017</study_first_posted>
  <last_update_submitted>January 11, 2018</last_update_submitted>
  <last_update_submitted_qc>January 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Visual Disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Vision Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

